| K-number | K203220 |
| Device name | cobas BKV |
| Applicant | Roche Molecular Systems, Inc. |
| Product code | QLX |
| Device class | Class II |
| Decision date | Jan 29, 2021 |
| Decision | Substantially Equivalent |
| Regulation | 866.3183 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov